The Food and Drug Administration (FDA) licensed Wegovy towards the end of December on the back of results from the OASIS 4 trial that showed the 25mg dose led to a mean weight loss of 16.6 percent
These medications, widely used for managing Type 2 diabetes and obesity, have gained popularity for their weight loss benefits
Diabetes Obes Metab 2017;19:33647
5 weight loss doctors serving Omaha offer virtual GLP-1 consultations, allowing you to get a semaglutide or tirzepatide prescription and have medication shipped to your door without an in-person visit
Several preventative measures have been established and continue to evolve, addressing AMR at international, national, community, hospital, and individual levels (Uchil et al., 2014)